DC-CIK cell therapy
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for DC-CIK cell therapy, covering 2015-07-22 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer. [EARLY_Phase 1]